Lung carcinoid tumours: histology and Ki‐67, the eternal rivalry. Issue 2 (26th October 2022)
- Record Type:
- Journal Article
- Title:
- Lung carcinoid tumours: histology and Ki‐67, the eternal rivalry. Issue 2 (26th October 2022)
- Main Title:
- Lung carcinoid tumours: histology and Ki‐67, the eternal rivalry
- Authors:
- Centonze, Giovanni
Maisonneuve, Patrick
Simbolo, Michele
Lagano, Vincenzo
Grillo, Federica
Fabbri, Alessandra
Prinzi, Natalie
Garzone, Giovanna
Filugelli, Martina
Pardo, Carlotta
Mietta, Alessia
Pusceddu, Sara
Sabella, Giovanna
Bercich, Luisa
Mangogna, Alessandro
Rolli, Luigi
Grisanti, Salvatore
Benvenuti, Mauro Roberto
Pastorino, Ugo
Roz, Luca
Scarpa, Aldo
Berruti, Alfredo
Capella, Carlo
Milione, Massimo - Abstract:
- Abstract : WHO classification of Thoracic Tumours defines lung carcinoid tumours (LCTs) as well‐differentiated neuroendocrine neoplasms (NENs) classified in low grade typical (TC) and intermediate grade atypical carcinoids (AC). Limited data exist concerning protein expression and morphologic factors able to predict disease aggressiveness. Though Ki‐67 has proved to be a powerful diagnostic and prognostic factor for Gastro‐entero‐pancreatic NENs, its role in lung NENs is still debated. A retrospective series of 370 LCT from two oncology centers was centrally reviewed. Morphology and immunohistochemical markers (Ki‐67, TTF‐1, CD44, OTP, SSTR‐2A, Ascl1, and p53) were studied and correlated with Overall Survival (OS), Cancer‐specific survival (CSS) and Disease‐free survival (DFS). Carcinoid histology was confirmed in 355 patients: 297 (83.7%) TC and 58 (16.3%) AC. Ki‐67 at 3% was the best value in predicting DFS. Ki‐67 ≥ 3% tumours were significantly associated with AC histology, stage III‐IV, smoking, vascular invasion, tumour spread through air spaces OTP negativity, and TTF‐1, Ascl1 and p53 positivity. After adjustment for center and period of diagnosis, both Ki‐67 (≥3 versus <3) and histology (AC versus TC) alone significantly added prognostic information to OS and CSS multivariable model with age, stage and OTP; addition of both variables did not provide further prognostic information. Conversely, an improved significance of the DFS prediction model at multivariateAbstract : WHO classification of Thoracic Tumours defines lung carcinoid tumours (LCTs) as well‐differentiated neuroendocrine neoplasms (NENs) classified in low grade typical (TC) and intermediate grade atypical carcinoids (AC). Limited data exist concerning protein expression and morphologic factors able to predict disease aggressiveness. Though Ki‐67 has proved to be a powerful diagnostic and prognostic factor for Gastro‐entero‐pancreatic NENs, its role in lung NENs is still debated. A retrospective series of 370 LCT from two oncology centers was centrally reviewed. Morphology and immunohistochemical markers (Ki‐67, TTF‐1, CD44, OTP, SSTR‐2A, Ascl1, and p53) were studied and correlated with Overall Survival (OS), Cancer‐specific survival (CSS) and Disease‐free survival (DFS). Carcinoid histology was confirmed in 355 patients: 297 (83.7%) TC and 58 (16.3%) AC. Ki‐67 at 3% was the best value in predicting DFS. Ki‐67 ≥ 3% tumours were significantly associated with AC histology, stage III‐IV, smoking, vascular invasion, tumour spread through air spaces OTP negativity, and TTF‐1, Ascl1 and p53 positivity. After adjustment for center and period of diagnosis, both Ki‐67 (≥3 versus <3) and histology (AC versus TC) alone significantly added prognostic information to OS and CSS multivariable model with age, stage and OTP; addition of both variables did not provide further prognostic information. Conversely, an improved significance of the DFS prediction model at multivariate analysis was seen by adding Ki‐67 (≥3 versus <3, P adj = 0.01) to TC and AC histological distinction, age, lymph node involvement, residual tumour and OTP. Ki‐67 ≥ 3% plays a potentially pivotal role in LCT prognosis, irrespective of histological grade. Abstract : Lung Carcinoid Tumours: Histology or Ki‐67 Index? … (more)
- Is Part Of:
- Histopathology. Volume 82:Issue 2(2023)
- Journal:
- Histopathology
- Issue:
- Volume 82:Issue 2(2023)
- Issue Display:
- Volume 82, Issue 2 (2023)
- Year:
- 2023
- Volume:
- 82
- Issue:
- 2
- Issue Sort Value:
- 2023-0082-0002-0000
- Page Start:
- 324
- Page End:
- 339
- Publication Date:
- 2022-10-26
- Subjects:
- lung carcinoid tumours -- neuroendocrine neoplasms -- Ki‐67 index -- OTP -- immunohistochemistry
Histology, Pathological -- Periodicals
611.018 - Journal URLs:
- http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=his ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2559 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/his.14819 ↗
- Languages:
- English
- ISSNs:
- 0309-0167
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4316.027000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24670.xml